Literature DB >> 28545625

A Home-Based Walking Program Improves Respiratory Endurance in Patients With Acute Myocardial Infarction: A Randomized Controlled Trial.

Bruna C Matos-Garcia1, Isadora S Rocco1, Lara D Maiorano2, Thatiana C A Peixoto2, Rita Simone L Moreira2, Antonio C C Carvalho2, Aparecida Maria Catai3, Ross Arena4, Walter J Gomes2, Solange Guizilini5.   

Abstract

BACKGROUND: The purpose of this study was to evaluate respiratory muscle strength and endurance in the inpatient period in patients who recently experienced myocardial infarction (MI) and investigate the effects of a home-based walking program on respiratory strength and endurance in low-risk patients after MI.
METHODS: Patients were randomized into a usual-care group (UCG) entailing regular care (n = 23) and an intervention group (IG) entailing an outpatient home-based walking program (n = 31). Healthy sex- and age-matched participants served as a control group for respiratory endurance variables. Respiratory muscle strength was evaluated through maximal inspiratory pressure (MIP) and endurance during the inpatient period, at 15 days, and at 60 days after MI. Submaximal functional capacity was determined by a 6-minute walk test (6MWT) at hospital discharge and 60 days after MI.
RESULTS: Both groups showed impaired inspiratory muscle strength at hospital discharge. When compared with healthy individuals, after MI, patients had worse respiratory muscle endurance pressure (PTHmax = 73.02 ± 8.40 vs 44.47 ± 16.32; P < 0.05) and time (Tlim = 324.1 ± 12.2 vs 58.7 ± 93.3; P < 0.05). Only the IG showed a significant improvement in MIP and PTHmax at 15 days and 60 days after MI (P < 0.05). When comparing groups, the IG achieved higher values for MIP, PTHmax, and Tlim 15 and 60 days after MI (P < 0.01). The 60-day assessment revealed that the 6MWT distance and level of physical activity was significantly higher in the IG compared with the UCG.
CONCLUSIONS: Low-risk patients recently experiencing MI demonstrate impaired MIP and respiratory endurance compared with healthy participants. A home-based walking program improved respiratory endurance and functional capacity.
Copyright © 2017 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28545625     DOI: 10.1016/j.cjca.2016.12.004

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  5 in total

Review 1.  Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.

Authors:  Joshua R Smith; Bryan J Taylor
Journal:  Prog Cardiovasc Dis       Date:  2021-10-22       Impact factor: 8.194

2.  The Safety and Efficacy of Inspiratory Muscle Training for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Study Protocol for a Randomized Controlled Trial.

Authors:  YuanHui Liu; YiNing Dai; Zhi Liu; HuiMin Zhan; Manyu Zhu; XianYuan Chen; ShengQing Zhang; GuoLin Zhang; Ling Xue; ChongYang Duan; JiYan Chen; Lan Guo; PengCheng He; Ning Tan
Journal:  Front Cardiovasc Med       Date:  2021-01-12

3.  Effect of home-based high-intensity interval training versus moderate-intensity continuous training in patients with myocardial infarction: a randomized controlled trial.

Authors:  Hazal Yakut; Hüseyin Dursun; Elvan Felekoğlu; Ahmet Anıl Başkurt; Aylin Özgen Alpaydın; Sevgi Özalevli
Journal:  Ir J Med Sci       Date:  2022-01-07       Impact factor: 2.089

4.  A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.

Authors:  Mary Beth Brown; Attie Kempf; Catherine M Collins; Gary M Long; Matthew Owens; Shikha Gupta; Yaron Hellman; Vincent Wong; Mark Farber; Tim Lahm
Journal:  Pulm Circ       Date:  2018 Jan-Mar       Impact factor: 3.017

Review 5.  The Beneficial Role of Exercise Training for Myocardial Infarction Treatment in Elderly.

Authors:  Ying Xing; Si-Dong Yang; Man-Man Wang; Ya-Shuo Feng; Fang Dong; Feng Zhang
Journal:  Front Physiol       Date:  2020-04-24       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.